GUMDROP : VEG113387 A Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Pazopanib as Adjuvant Therapy for Subjects with Localized or Locally Advanced RCC Following Nephrectomy

Created by Nancy Dawson, last modified on Apr 28, 2013

Description:

To evaluate the efficacy and safety of pazopanib compared to sunitinib in subjects with advanced RCC who have not received prior systemic therapy for advanced or metastatic RCC.

Link:

http://clinicaltrials.gov/ct2/show/study/NCT01235962

Site:

Georgetown University Hospital

Principal Investigator:

Dr. Nancy A. Dawson